Search
Fate Therapeutics Inc
FATEAdd to Watchlist
2.570USD
+0.050+1.98%
Close 08-14 16:00（ET）Quotes delayed by 15 min
307.94MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+1.98%
5 Days
-8.21%
1 Month
-14.05%
6 Months
+105.60%
Year to Date
+161.55%
1 Year
+135.78%
Key Figures
2.580Open
2.600High
2.00MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.71%Turnover Ratio
2.520Prev. Close
2.480Low
4.21MTurnover
LossP/E Static
1.95P/B
0.00%Div Yield TTM
-38.01%ROA
2.66552wk High
0.92Volume Ratio
-186.26MNet Profit
116.69MShares
-1.0898EPS TTM
2.42Beta
-55.50%ROE
0.91052wk Low
4.76%Amplitude
100.00%Gross Margin
307.94MMarket Cap
-1.66Reward/Risk
5.64%Risk Rate
More news coming soon, stay tuned...
Fate Therapeutics Inc's Score
0.00vs previous score
Forecast7.50
Financial Health5.73
Technical4.46
Valuation Dimensions6.10
Institutional Confidence7.00
Risk Assessment2.87
Media Coverage
Coverage Level
Very Low
Very High
Negative
Analyst Rating
Fate Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
2026-08-13
Reporting Period
2026Q2
Earnings / Forecast
-0.25/-0.27
Revenue / Forecast
2.08M/1.37M
Fate Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolFATE
Number of employees181
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Redmile Group, LLC | 11.08% |
| ARK Investment Management LLC | 8.87% |
| Wilshire Advisors LLC | 7.30% |
| BlackRock Institutional Trust Company, N.A. | 6.93% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 32.10% |
| Investment Advisor | 30.78% |
| Hedge Fund | 10.23% |
| Venture Capital | 3.22% |
Related Instruments
-2.23%
-0.66%
-0.52%
+0.23%
-0.54%
-0.61%
-0.63%
+0.16%
-1.78%
-0.07%
-1.25%
-2.07%
-0.14%
+1.37%
-0.92%
-0.31%
+1.44%
+1.69%
-0.66%
+0.85%Popular Instruments
53701.000
-163.700 (-0.30%)
30056.300
-54.300 (-0.18%)
7781.100
-21.900 (-0.28%)
14878.000
-75.000 (-0.50%)
68691.000
-403.000 (-0.58%)
6546.100
-16.700 (-0.25%)
81.375
+1.264 (+1.58%)
305.930
+0.670 (+0.22%)
225.160
-0.140 (-0.06%)
4376.180
+26.550 (+0.61%)
FAQs
What is the current price of Fate Therapeutics Inc (FATE)?
The current price of Fate Therapeutics Inc (FATE) is 2.57.
What is the symbol of Fate Therapeutics Inc?
The ticker symbol of Fate Therapeutics Inc is FATE.
What is the 52-week high of Fate Therapeutics Inc?
The 52-week high of Fate Therapeutics Inc is 2.67.
What is the 52-week low of Fate Therapeutics Inc?
The 52-week low of Fate Therapeutics Inc is 0.91.
What is the market capitalization of Fate Therapeutics Inc?
The market capitalization of Fate Therapeutics Inc is 299.90M.
Is Fate Therapeutics Inc (FATE) currently rated as Buy, Hold, or Sell?
According to analysts, Fate Therapeutics Inc (FATE) has an overall rating of Buy, with a price target of 5.74.
What is the Earnings Per Share (EPS TTM) of Fate Therapeutics Inc (FATE)?
The Earnings Per Share (EPS TTM) of Fate Therapeutics Inc (FATE) is -1.09.